or Try an Advanced Search...

    Technical Analysis for ENSC - Ensysce Biosciences, Inc.

    Grade Last Price % Change Price Change
    F 0.50 -1.32% -0.01
    ENSC closed down 1.32 percent on Monday, July 1, 2024, on 74 percent of normal volume. The bears made the stock sink to a new 52-week low.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ENSC trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    New 52 Week Closing Low Bearish 0.00%
    Doji - Bullish? Reversal 0.00%
    New 52 Week Low Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    New 52 Week Low Weakness -1.32%
    Gapped Down Weakness -1.32%
    Lower Bollinger Band Touch Weakness -1.32%
    NR7 Range Contraction -6.74%
    Older End-of-Day Signals for ENSC ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 9 hours ago
    Down 3% about 9 hours ago
    Fell Below Lower Bollinger Band about 9 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    Down 2 % about 9 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ENSC Chart by TradingView
    Basic chart:

    Profile

    Ensysce Biosciences, San Diego, CA is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin Activated Abuse Protection (TAAP™) and Multi-Pill Abuse Resistance (MPAR™) platforms, the Company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce’s products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing the human and economic cost. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Health Sciences Pain Pharmacy Psychoactive Drugs Opioids Heroin Morphine Drug Culture Opioid Use Disorder

    Is ENSC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting
    Jun 25 Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate
    Jun 6 Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
    Jun 3 Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting
    May 28 Ensysce Biosciences regains Nasdaq compliance
    May 28 Ensysce Biosciences Regains Compliance with Nasdaq
    May 20 Sector Update: Health Care Stocks Softer Late Afternoon
    May 20 Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform
    May 14 Ensysce Biosciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    May 13 Ensysce Biosciences GAAP EPS of -$0.55
    See more ENSC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.34
    52 Week Low 0.47
    Average Volume 153,488
    200-Day Moving Average 0.95
    50-Day Moving Average 0.57
    20-Day Moving Average 0.54
    10-Day Moving Average 0.52
    Average True Range 0.05
    RSI (14) 40.83
    ADX 28.6
    +DI 9.71
    -DI 23.17
    Chandelier Exit (Long, 3 ATRs) 0.46
    Chandelier Exit (Short, 3 ATRs) 0.61
    Upper Bollinger Bands 0.59
    Lower Bollinger Band 0.49
    Percent B (%b) 0.11
    BandWidth 18.01
    MACD Line -0.02
    MACD Signal Line -0.02
    MACD Histogram -0.0002
    Fundamentals Value
    Market Cap 1.57 Million
    Num Shares 3.15 Million
    EPS -1.86
    Price-to-Earnings (P/E) Ratio -0.27
    Price-to-Sales 1.15
    Price-to-Book 2.50
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.56
    Resistance 3 (R3) 0.56 0.53 0.55
    Resistance 2 (R2) 0.53 0.52 0.53 0.55
    Resistance 1 (R1) 0.52 0.51 0.50 0.52 0.54
    Pivot Point 0.49 0.49 0.49 0.49 0.49
    Support 1 (S1) 0.48 0.48 0.46 0.48 0.46
    Support 2 (S2) 0.45 0.47 0.45 0.45
    Support 3 (S3) 0.44 0.45 0.45
    Support 4 (S4) 0.44